Overview

4-aminopyridine Treatment for Nerve Injury

Status:
Recruiting
Trial end date:
2025-08-05
Target enrollment:
Participant gender:
Summary
To evaluate the role of 4-aminopyridine (4-AP) on the course of recovery after peripheral nerve traction and/or crush injury. This study aims to test the hypothesis that 4-aminopyridine speeds the often slow and unpredictable recovery after peripheral nerve traction and/or crush injuries.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Milton S. Hershey Medical Center
University of Rochester
Collaborators:
Milton S. Hershey Medical Center
University of Rochester
Treatments:
4-Aminopyridine